WebDec 11, 2024 · Since being FDA-approved for treating iron-deficiency anemia, Feraheme has attracted considerable attention and is increasingly being used off-label as an MR imaging contrast agent, not only as an alternative to conventional gadolinium-based agents but also because of its unique and favorable pharmacologic, metabolic and imaging … WebApr 3, 2015 · When Feraheme received FDA approval in 2009, this risk was described in the Warnings and Precautions section of the drug label. Since then, serious reactions, including deaths, have occurred despite the …
Specialty Specific – Feraheme
WebFeb 5, 2024 · Feraheme FDA Approval History. FDA Approved: Yes (First approved June 30, 2009) Brand name: Feraheme Generic name: ferumoxytol Dosage form: Intravenous Injection Company: AMAG Pharmaceuticals, Inc. Treatment for: Anemia Associated with Chronic Renal Failure, Iron Deficiency Anemia Feraheme (ferumoxytol) is an iron … WebFerumoxytol (marketed as Feraheme® in North America and Rienso® elsewhere) is an ultrasmall superparamagnetic iron oxide (USPIO) approved for intravenous treatment of iron-deficiency anemia associated with chronic renal disease.Each particle consists of a core of approximately 2000 magnetite (Fe3O4) molecules surrounded by a carbohydrate … how to make my own wordsearch
ferumoxytol - Questions and Answers in MRI
WebFeraheme is indicated for the treatment of iron deficiency anemia (IDA) in adult patients: who have intolerance to oral iron or have had unsatisfactory response to oral iron or who … WebMay 2, 2024 · Feraheme is contraindicated in patients with a known hypersensitivity to Feraheme or any of its components, or a history of allergic reaction to any intravenous … WebFeb 5, 2024 · Feraheme FDA Approval History. FDA Approved: Yes (First approved June 30, 2009) Brand name: Feraheme Generic name: ferumoxytol Dosage form: Intravenous … msw programs in washington dc